About Us

Doug Holt, MD

Founder and Creator

Read bio...

Dr. Douglas Holt is a radiation oncologist who is proficient in VMAT, SRS, SBRT, and complex interstitial brachytherapy. He is the co-founder and co-creator of RadFlix- a radiation compatible video distraction system used to reduce anxiety and anesthesia for adult and pediatric patients. He has had training at Memorial Sloan Kettering and was chief resident at University of Colorado.

Dr. Holt has a passion for improving the patient experience where he has been recognized for his efforts with grant funding and receiving the National Association of Community Cancer Centers (ACCC) Innovator of the Year Award with his work in pioneering the use of advanced imaging review during clinical consultations for patients and their caregivers. Dr. Holt takes care of patients at Eastern Idaho Regional Medical Center in Idaho Falls, ID and St. John’s Hospital in Jackson Hole, WY.

Brian Miller, PhD, DABR

Founder & Creator

Read bio...

Dr. Miller is a medical physicist and optical scientist. He earned a PhD from the University of Arizona, College of Optical Sciences in 2011, where his research focused on the development of high-resolution gamma-ray imaging systems. Currently, he practices clinical medical physics at the University of Arizona, Department of Radiation Oncology/Banner University Medical Center, Tucson, AZ.

Dr. Miller’s clinical research interests include development of video-based distraction therapy techniques for pediatric patients, additive manufacturing techniques for brachytherapy, and development of quality assurance imaging tools. Dr. Miller’s general research interests include: targeted radionuclide therapy with alpha and beta emitters, micro-scale dosimetry, quantitative digital autoradiography, intravital microscopy, scintillators, and radiation detector development. He is also the founder of QScint Imaging Solutions (www.qscint.com), which manufactures real-time quantitative digital autoradiography imaging systems for radiopharmaceutical therapy research.

Heather Roy

Executive Director

Read bio...

Heather is serving as the RadFlix Executive Director for both Canada and the United States.

Heather has extensive experience in the non-profit world, in particular with charities that support families dealing with a diagnosis of childhood cancer. Beyond her professional experience, Heather comes to us with personal experience in childhood cancer, having navigated a diagnosis of neuroblastoma with her daughter from 2018-2020. She has a huge heart for advocacy for better treatments and mental health support for childhood cancer patients, survivors, and their families.

Heather has a degree in Behavioural Sciences with a focus in Psychology. She has a particular interest in the mental health and well-being of children, adolescents, and their families.

Heather has been the recipient of several awards, including the prestigious Queen’s Platinum Jubilee Medal for her betterment of the province of Alberta where she currently lives with her family.

Joan Slaughter

Executive Director of
The Morgan Adams Foundation

Read bio...

Joan is the Executive Director of The Morgan Adams Foundation and is the mother of Morgan Adams. With a background in accounting, Joan was a member of a special projects divestiture team for a Fortune 100 company prior to Morgan’s diagnosis. After Morgan died, Joan and her late husband, Steven Adams, started the Foundation that bears their daughter’s name.

Joan serves as Executive Director and has focused her work on fundraising and raising community support for pediatric cancer research. Joan also serves on the Philanthropy Council of the Children’s Hospital Colorado Foundation Board, is the Chair of the Colorado Kids’ Cancer Association, and serves as a Patient Advocate on the NIH’s Pediatric Central Institutional Review Board. Joan and Steven have two other children, Andrew and Sara Grace.

Heather has extensive experience in the non-profit world, in particular with charities that support families dealing with a diagnosis of childhood cancer. Beyond her professional experience, Heather comes to us with personal experience in childhood cancer, having navigated a diagnosis of neuroblastoma with her daughter from 2018-2020. She has a huge heart for advocacy for better treatments and mental health support for childhood cancer patients, survivors, and their families.

Heather has a degree in Behavioural Sciences with a focus in Psychology. She has a particular interest in the mental health and well-being of children, adolescents, and their families.

Heather has been the recipient of several awards, including the prestigious Queen’s Platinum Jubilee Medal for her betterment of the province of Alberta where she currently lives with her family.

About The Morgan Adams Foundation

The Morgan Adams Foundation (MAF) funds kids’ cancer research.  MAF raises awareness of, and educates communities about, the need for pediatric and young adult specific cancer treatments.

Working with leading researchers and physicians, MAF funds new and innovative ideas that will improve cancer treatment effectiveness, overall outcomes, survival rates and quality of life while minimizing the devastating side effects current treatments have on our children.

MAF’s particular interest is to provide seed and bridge grants for viable investigations not yet ripe enough for total funding by larger organizations. Additionally, they are able to partially fund translational studies, experimental therapeutics studies, and/or Phase I and II clinical trials on a case-by-case basis.

MAF increasingly seeks projects that are highly collaborative and/or multi-institutional in nature. Their hope is that they can facilitate, through strategic funding, more rapid clinical trial development to get the best possible treatment options into circulation as expediently as possible.

Through careful consideration and placement of our funding, MAF encourages and supports research intended to improve treatment effectiveness, treatment outcomes, and the quality of life for children battling cancer.